Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-expressed protein 15 (TEX15) is a large, serine-rich protein encoded by the TEX15 gene on chromosome 8p12, displaying highly testis-specific expression[1][3][4]. TEX15 is essential for male germ cell development and fertility, playing a critical role in meiotic processes through facilitating DNA double-strand break repair, chromosome synapsis, and recombination in spermatocytes[1][3][4]. It acts as a key factor in the proper loading of repair proteins, such as RAD51 and DMC1, onto meiotic chromosomes and is indispensable for the epigenetic silencing of transposable elements (TEs), functioning as a nuclear effector that interacts with PIWI proteins (MIWI2 and MILI) to mediate de novo TE DNA methylation[2][5]. Male mice deficient in TEX15 are infertile due to meiotic arrest and extensive genome instability; in humans, rare variants of the TEX15 gene have been implicated as a monogenic cause of spermatogenic failure and, in some reports, as possible risk factors for breast cancer[1][3][4]. There are currently no known drugs targeting TEX15, nor is it considered a therapeutic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-expressed protein 15 (TEX15).